Because serum YKL-40 was previously reported to be elevated in other autoimmune diseases and in OA [28, 29], we compared serum YKL-40 among patients with AAV and those with SLE, RA, OA, and HC. This evidence concerns the gene CHI3L1 and systemic lupus erythematosus.